Group B Streptococcus (GBS, a.k.a. Streptococcus agalactiae) is an opportunistic pathogen and a major cause of neonatal invasive disease, with a particular impact on infant mortality in low and middle-income countries (LMICs). We will conduct whole genome sequencing of GBS isolates from across a broad geographical and temporal span to better understand pathogen diversity, pathogen genetic association with the disease and pathogen transmission. The analysis outputs will serve to inform future disease prevention and treatment strategies.
The generated data will be made freely available through open online platforms.